CBD reduced the rewarding effects of cocaine in rats through CB2, serotonin, and TRPV1 receptors

CBD dose-dependently reduced cocaine self-administration and cocaine-enhanced brain reward in rats by blocking cocaine-induced dopamine increases in the nucleus accumbens, working through CB2, 5-HT1A, and TRPV1 receptors.

Galaj, Ewa et al.·Neuropharmacology·2020·Preliminary EvidenceAnimal StudyAnimal Study
RTHC-02564Animal StudyPreliminary Evidence2020RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

CBD (10-40 mg/kg) reduced cocaine self-administration, shifted the cocaine dose-response curve downward, and lowered break-points for cocaine seeking. CBD also attenuated cocaine-enhanced brain stimulation reward. These effects were blocked by CB2, 5-HT1A, and TRPV1 antagonists but not by CB1, GPR55, or opioid receptor antagonists.

Key Numbers

CBD doses: 10-40 mg/kg for self-administration, 3-20 mg/kg for brain stimulation reward. CBD blocked cocaine-induced dopamine increases in the nucleus accumbens. Effects mediated by CB2, 5-HT1A, and TRPV1, not CB1 or opioid receptors.

How They Did This

Rat study using intravenous cocaine self-administration, progressive-ratio reinforcement schedules, intracranial brain-stimulation reward, and in vivo microdialysis to measure dopamine levels in the nucleus accumbens.

Why This Research Matters

No FDA-approved medication exists for cocaine use disorder. This study identifies specific receptor mechanisms through which CBD reduces cocaine reward, providing a roadmap for clinical development.

The Bigger Picture

The finding that CBD acts through CB2 rather than CB1 receptors is significant because CB1 drugs often produce unwanted psychoactive effects, while CB2-targeted approaches may avoid this problem.

What This Study Doesn't Tell Us

Animal study results may not translate directly to humans. CBD was effective against lower cocaine doses but not high doses, suggesting it may not help the most severe cases. The specific receptor interactions need verification in humans.

Questions This Raises

  • ?Would CBD reduce cocaine craving and relapse in human clinical trials?
  • ?Why was CBD ineffective against high cocaine doses?
  • ?Could combination therapies targeting multiple receptor pathways improve efficacy?

Trust & Context

Key Stat:
CBD blocked cocaine-induced dopamine via CB2, 5-HT1A, and TRPV1
Evidence Grade:
Preliminary: animal study with detailed mechanistic analysis, but not yet tested in humans.
Study Age:
Published in 2020 in Neuropharmacology.
Original Title:
Cannabidiol attenuates the rewarding effects of cocaine in rats by CB2, 5-HT1A and TRPV1 receptor mechanisms.
Published In:
Neuropharmacology, 167, 107740 (2020)
Database ID:
RTHC-02564

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

How does CBD reduce cocaine reward?

CBD appears to dampen the dopamine surge that cocaine produces in the brain's reward center (nucleus accumbens). Without this dopamine spike, cocaine becomes less rewarding. CBD achieves this through CB2, serotonin, and TRPV1 receptors.

Could this lead to a treatment for cocaine addiction?

Potentially, but significant hurdles remain. CBD only reduced self-administration of lower cocaine doses, and these are animal results. Human clinical trials would be needed to determine if CBD could help people reduce cocaine use.

Read More on RethinkTHC

Cite This Study

RTHC-02564·https://rethinkthc.com/research/RTHC-02564

APA

Galaj, Ewa; Bi, Guo-Hua; Yang, Hong-Ju; Xi, Zheng-Xiong. (2020). Cannabidiol attenuates the rewarding effects of cocaine in rats by CB2, 5-HT1A and TRPV1 receptor mechanisms.. Neuropharmacology, 167, 107740. https://doi.org/10.1016/j.neuropharm.2019.107740

MLA

Galaj, Ewa, et al. "Cannabidiol attenuates the rewarding effects of cocaine in rats by CB2, 5-HT1A and TRPV1 receptor mechanisms.." Neuropharmacology, 2020. https://doi.org/10.1016/j.neuropharm.2019.107740

RethinkTHC

RethinkTHC Research Database. "Cannabidiol attenuates the rewarding effects of cocaine in r..." RTHC-02564. Retrieved from https://rethinkthc.com/research/galaj-2020-cannabidiol-attenuates-the-rewarding

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.